Occupational therapy in spinocerebellar ataxia type 3: an open-label trial

Occupational therapy in spinocerebellar ataxia type 3: an open-label trial

Occupational therapy (OT) is a profession concerned with promoting health and well-being through occupation, by enabling handicapped people to participate in the activities of everyday life. OT is part of the clinical rehabilitation of progressive genetic neurodegenerative diseases such as spinocere...

Full description

Bibliographic Details
Main Authors:	R.C.R. Silva, J.A.M. Saute, A.C.F. Silva, A.C.O. Coutinho, M.L. Saraiva-Pereira, L.B. Jardim
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2010-06-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Spinocerebellar ataxia 3 Occupational therapy Rehabilitation Depression Machado-Joseph disease Polyglutamine diseases
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010000600003

Similar Items

Itajaí, Santa Catarina – Azorean ancestry and spinocerebellar ataxia type 3
by: Hélio A. G. Teive, et al.

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
by: Adriano M. de Assis, et al.
Published: (2017-09-01)

Assessment of Bone Mineral Density of Patients with Spinocerebellar Ataxia Type 3
by: Aline MS Farias, et al.
Published: (2019-01-01)

Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein
by: Naila S. Ashraf, et al.
Published: (2020-04-01)

Neural correlates of ataxia severity in spinocerebellar ataxia type 3/Machado-Joseph disease
by: Carlos R. Hernandez-Castillo, et al.
Published: (2017-06-01)

A transgenic mouse model of spinocerebellar ataxia type 3 resembling late disease onset and gender-specific instability of CAG repeats
by: Jana Boy, et al.
Published: (2010-02-01)

Dataset on the effect of Rubicon overexpression on polyglutamine-induced locomotor dysfunction in Drosophila
by: Masaki Oba, et al.
Published: (2021-08-01)

The SCA1 (Spinocerebellar ataxia type 1) and MJD (Machado-Joseph disease) CAG repeats in normal individuals: segregation analysis and allele frequencies
by: Cláudia Emília Vieira Wiezel, et al.
Published: (2003-01-01)

Trehalose alleviates the phenotype of Machado–Joseph disease mouse models
by: Magda M. Santana, et al.
Published: (2020-04-01)

Sodium valproate increases activity of the sirtuin pathway resulting in beneficial effects for spinocerebellar ataxia-3 in vivo
by: Maxinne Watchon, et al.
Published: (2021-08-01)

Chemical Chaperones Reduce Aggregate Formation and Cell Death Caused by the Truncated Machado–Joseph Disease Gene Product with an Expanded Polyglutamine Stretch
by: Hideaki Yoshida, et al.
Published: (2002-07-01)

Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado–Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies
by: Yu-Shuan Chen, et al.
Published: (2020-04-01)

A Mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado–Joseph disease-like transgenic mice
by: Veronica F. Colomer Gould, et al.
Published: (2007-09-01)

Clinical and genetic profile in index patients with spinocerebellar ataxia type 3 in Indonesia: case report
by: Siti Aminah, et al.
Published: (2021-07-01)

State biomarkers for Machado Joseph disease: Validation, feasibility and responsiveness to change
by: Gabriel Vasata Furtado, et al.

Genetic Modeling of the Neurodegenerative Disease Spinocerebellar Ataxia Type 1 in Zebrafish
by: Mohamed A. Elsaey, et al.
Published: (2021-07-01)

A frequência de câncer na doença de Machado-Joseph
by: Souza, Gabriele Nunes
Published: (2016)

A frequência de câncer na doença de Machado-Joseph
by: Souza, Gabriele Nunes
Published: (2016)

A frequência de câncer na doença de Machado-Joseph
by: Souza, Gabriele Nunes
Published: (2016)

História natural da ataxia espinocerebelar tipo 3/Doença de Machado-Joseph com início na infância
by: Donis, Karina Carvalho
Published: (2015)

História natural da ataxia espinocerebelar tipo 3/Doença de Machado-Joseph com início na infância
by: Donis, Karina Carvalho
Published: (2015)

História natural da ataxia espinocerebelar tipo 3/Doença de Machado-Joseph com início na infância
by: Donis, Karina Carvalho
Published: (2015)

Population genetics of spinoсerebellar ataxias caused by polyglutamine expansions
by: A. N. Shuvaev, et al.
Published: (2019-07-01)

A família Drew de Walworth: um século após a avaliação inicial finalmente o diagnóstico doença de Machado-Joseph The Drew family of Walworth: one century from the first evaluation until the final diagnosis, Machado-Joseph disease
by: Hélio A. Ghizoni Teive, et al.
Published: (2004-03-01)

RNA Expression Profile and Potential Biomarkers in Patients With Spinocerebellar Ataxia Type 3 From Mainland China
by: Tianjiao Li, et al.
Published: (2019-06-01)

Ophthalmic Manifestations and Genetics of the Polyglutamine Autosomal Dominant Spinocerebellar Ataxias: A Review
by: Jun Young Park, et al.
Published: (2020-08-01)

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion
by: Anna Niewiadomska-Cimicka, et al.
Published: (2020-06-01)

Characterization of Lifestyle in Spinocerebellar Ataxia Type 3 and Association with Disease Severity
by: Bushara, K., et al.
Published: (2022)

Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches
by: Luis C. Velázquez-Pérez, et al.
Published: (2017-09-01)

Altered Plasma Acylcarnitines and Amino Acids Profile in Spinocerebellar Ataxia Type 7
by: Rafael Nambo-Venegas, et al.
Published: (2020-03-01)

Polyglutamine toxicity induces rod photoreceptor division, morphological transformation or death in Spinocerebellar ataxia 7 mouse retina
by: Marina G. Yefimova, et al.
Published: (2010-10-01)

Toward understanding the role of protein context in the polyglutamine disease, SCA3
by: Harris, Ginny Marie
Published: (2011)

Frequency of the different mutations causing spinocerebellar ataxia (SCA1, SCA2, MJD/SCA3 and DRPLA) in a large group of Brazilian patients Freqüência das mutações que causam ataxia espinocerebelar (SCA1, SCA2, MJD/SCA3 e DRPLA) em um grupo numeroso de pacientes Brasileiros
by: Iscia Lopes-Cendesi, et al.
Published: (1997-09-01)

Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models
by: Lauren R. Moore, et al.
Published: (2017-06-01)

Machado-Joseph Disease
by: J Gordon Millichap
Published: (1996-06-01)

Sleep disorders among Aboriginal Australians with Machado-Joseph Disease: Quantitative results from a multiple methods study to assess the experience of people living with the disease and their caregivers
by: Barker, R., et al.
Published: (2022)

Aspectos clínicos e bioquímicos da Doença de Machado-Joseph : da descrição de novos biomarcadores à busca de um tratamento efetivo
by: Saute, Jonas Alex Morales
Published: (2016)

Aspectos clínicos e bioquímicos da Doença de Machado-Joseph : da descrição de novos biomarcadores à busca de um tratamento efetivo
by: Saute, Jonas Alex Morales
Published: (2016)

Aspectos clínicos e bioquímicos da Doença de Machado-Joseph : da descrição de novos biomarcadores à busca de um tratamento efetivo
by: Saute, Jonas Alex Morales
Published: (2016)

Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: Removal of the CAG containing exon
by: Melvin M. Evers, et al.
Published: (2013-10-01)